Cargando…
Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host
The fungal cytochrome P450 lanosterol 14α-demethylase (CYP51) is required for the biosynthesis of fungal-specific ergosterol and is the target of azole antifungal drugs. Despite proven success as a clinical target for azole antifungals, there is an urgent need to develop next-generation antifungals...
Autores principales: | Ruma, Yasmeen N., Keniya, Mikhail V., Tyndall, Joel D. A., Monk, Brian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781857/ https://www.ncbi.nlm.nih.gov/pubmed/35050009 http://dx.doi.org/10.3390/jof8010069 |
Ejemplares similares
-
Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target
por: Ruma, Yasmeen N., et al.
Publicado: (2022) -
Structural Insights into the Azole Resistance of the Candida albicans Darlington Strain Using Saccharomyces cerevisiae Lanosterol 14α-Demethylase as a Surrogate
por: Graham, Danyon O., et al.
Publicado: (2021) -
Functional Expression of Recombinant Candida auris Proteins in Saccharomyces cerevisiae Enables Azole Susceptibility Evaluation and Drug Discovery
por: Toepfer, Stephanie, et al.
Publicado: (2023) -
Pathogenesis of the Candida
parapsilosis Complex in the Model Host Caenorhabditis elegans
por: Souza, Ana Carolina Remondi, et al.
Publicado: (2018) -
Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris
por: Toepfer, Stephanie, et al.
Publicado: (2023)